Equities analysts forecast that Milacron Holdings Corp (NYSE:MCRN) will post $302.65 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Milacron’s earnings, with the highest sales estimate coming in at $304.60 million and the lowest estimate coming in at $299.68 million. Milacron posted sales of $289.10 million in the same quarter last year, which suggests a positive year-over-year growth rate of 4.7%. The business is expected to announce its next quarterly earnings results on Thursday, February 22nd.

According to Zacks, analysts expect that Milacron will report full year sales of $302.65 million for the current fiscal year. For the next year, analysts expect that the company will report sales of $1.26 billion per share, with estimates ranging from $1.25 billion to $1.27 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow Milacron.

Milacron (NYSE:MCRN) last posted its earnings results on Thursday, October 26th. The industrial products company reported $0.44 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.02. Milacron had a negative net margin of 0.09% and a negative return on equity of 56.93%. The company had revenue of $314.70 million for the quarter, compared to analyst estimates of $301.13 million. During the same quarter in the prior year, the business posted $0.36 EPS. The firm’s revenue was up 7.7% compared to the same quarter last year.

MCRN has been the topic of a number of analyst reports. BidaskClub upgraded shares of Milacron from a “strong sell” rating to a “sell” rating in a report on Thursday, September 28th. Robert W. Baird reiterated a “buy” rating and issued a $23.00 price objective on shares of Milacron in a research note on Wednesday, October 4th. Zacks Investment Research lowered shares of Milacron from a “hold” rating to a “sell” rating in a research note on Wednesday, October 11th. Finally, KeyCorp reiterated a “buy” rating and issued a $21.00 price objective on shares of Milacron in a research note on Friday, October 20th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Milacron has a consensus rating of “Buy” and an average target price of $21.67.

In other news, COO Ronald M. Krisanda sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 11th. The shares were sold at an average price of $18.11, for a total transaction of $181,100.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Ccmp Capital, Lp sold 10,974,093 shares of the firm’s stock in a transaction that occurred on Tuesday, November 21st. The stock was sold at an average price of $16.00, for a total transaction of $175,585,488.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,218,934 shares of company stock valued at $180,062,325. Company insiders own 3.40% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Public Employees Retirement System of Ohio increased its stake in shares of Milacron by 25.5% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 95,674 shares of the industrial products company’s stock worth $1,613,000 after purchasing an additional 19,416 shares during the last quarter. GSA Capital Partners LLP increased its stake in shares of Milacron by 874.1% during the 3rd quarter. GSA Capital Partners LLP now owns 182,424 shares of the industrial products company’s stock worth $3,076,000 after purchasing an additional 163,697 shares during the last quarter. Delphi Management Inc. MA increased its stake in shares of Milacron by 22.0% during the 3rd quarter. Delphi Management Inc. MA now owns 154,000 shares of the industrial products company’s stock worth $2,596,000 after purchasing an additional 27,736 shares during the last quarter. Algert Global LLC purchased a new stake in shares of Milacron during the 3rd quarter worth approximately $1,486,000. Finally, Walthausen & Co. LLC purchased a new stake in shares of Milacron during the 3rd quarter worth approximately $6,772,000. Institutional investors own 99.73% of the company’s stock.

Milacron (MCRN) traded down $0.29 on Thursday, hitting $17.91. 684,980 shares of the company were exchanged, compared to its average volume of 512,836. The company has a quick ratio of 1.31, a current ratio of 2.39 and a debt-to-equity ratio of -5.41. Milacron has a 12 month low of $15.09 and a 12 month high of $19.57. The firm has a market cap of $1,240.00 and a price-to-earnings ratio of 10.65.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/12/14/milacron-holdings-corp-mcrn-expected-to-post-quarterly-sales-of-302-65-million.html.

Milacron Company Profile

Milacron Holdings Corp. is engaged in the manufacture, distribution, and service of engineered and customized systems used in the plastic technology and processing industry. The Company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies.

Get a free copy of the Zacks research report on Milacron (MCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for Milacron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milacron and related stocks with our FREE daily email newsletter.